The absence of any new SARS-CoV-2 variant of concern designations by the WHO since March 2023 underpins the 81.5% trader consensus on “No.” Ongoing genomic surveillance continues to track Omicron sublineages such as BA.3.2 and XFG, which show notable spike mutations and have increased in detections across multiple countries since late 2025. Yet these strains remain classified only as variants under monitoring, with no evidence of substantially higher severity, immune escape, or transmission rates that would trigger a new concern label. Endemic circulation patterns and updated 2025–2026 vaccines aligned to dominant lineages further reinforce expectations that any further evolution will stay within existing categories through 2026.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourOui
$238,975 Vol.
$238,975 Vol.
Oui
$238,975 Vol.
$238,975 Vol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Marché ouvert : Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...The absence of any new SARS-CoV-2 variant of concern designations by the WHO since March 2023 underpins the 81.5% trader consensus on “No.” Ongoing genomic surveillance continues to track Omicron sublineages such as BA.3.2 and XFG, which show notable spike mutations and have increased in detections across multiple countries since late 2025. Yet these strains remain classified only as variants under monitoring, with no evidence of substantially higher severity, immune escape, or transmission rates that would trigger a new concern label. Endemic circulation patterns and updated 2025–2026 vaccines aligned to dominant lineages further reinforce expectations that any further evolution will stay within existing categories through 2026.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes